Roswellness Radio: Provenge Vaccine For Prostate Cancer

Sunday, June 12, 2011

Dr. Roberto Pili, Chief of the Genitourinary Section and Co-leader of the Genitourinary Program at RPCI, talks about Provenge, the first FDA-approved vaccine for the treatment of cancer. Joined by prostate-cancer survivor Russell Even, he talks about this drug, also known as sipuleucel-T, a new treatment option for some men with advanced prostate cancer.